Pedro Alvarez, MD
Family Practice · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Offices
- 7
Offices
7 locations · Stanford Health Care · Faculty Physicians and Surgeons of Llusm · Sac Health System · County of Santa Clara
Hospitals listed: Loma Linda University Medical Center. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Alvarez’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A163467 · Current
Licensed to practise in California · since 2019 · expires 2027-07-31 · University of California, Irvine College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 85.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Loma Linda University Medical CenterLoma Linda, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Loma Linda University Health, which runs 4 hospitalsPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.71 (0.47 to 0.96), Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.146, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.468, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.383, Oct 2024 – Sep 2025
See every measure and the patient survey for Loma Linda University Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 5 better, 2 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.71 (0.47 to 0.96) | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.146 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.468 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.383 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.66 (0 to 1.53) · 2,053 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 173.35 (135.58 to 211.11) · 169 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 54 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 79 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 285 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.6 · 272 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11 · 421 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 3,758 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,732 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.33 (0.15 to 0.52) · 8,479 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.88 (1.14 to 4.63) · 2,571 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.04 (0 to 2.41) · 933 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.85 (1.66 to 4.04) · 2,380 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.16 (0.2 to 10.13) · 908 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.42 (0.42 to 6.42) · 988 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.29 (0.91 to 3.67) · 677 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.37 (0 to 0.85) · 7,115 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 37 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.685 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.751 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.702 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.4 · 380 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 660 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 15.1 · 167 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 29.6 · 365 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -17.5 · 282 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.6 · 513 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (4 to 7.3) · 422 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (10.2 to 15.5) · 422 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.8 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.4 · 89 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.5 · 190 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.4 to 18.1) · 720 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 778 cases | No different | Jan 2024 – Dec 2024 |
What patients said (3,684 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$21,756
Medicare paid this office $21,756 for 118 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 68 | $11,865 | $60 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 59 | $6,087 | $92 |
| Hospital discharge day management, 30 minutes or less | 51 | $3,061 | $60 |
| Hemoglobin a1c level | 14 | $125 | $7 |
Who their Medicare patients are
118 Original Medicare patients in 2024. Average age 70 · Under 65 20% · 85 and older 15% · Women 60% · Also on Medicaid 57% · Health risk score 2.29. Sicker patients than 9 in 10 peers; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 58% · Chronic kidney disease 53% · Heart failure 38% · Depression 38% · Coronary heart disease 27% · COPD 26% · Stroke 25% · Atrial fibrillation 21% · Cancer 19% · Dementia 16%.
The office billed $83,396, Medicare allowed $28,715 and paid $21,756; for 343 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 118 | 343 | 70 | 2.29 | $83,396 | $21,756 |
| 2023 | 31 | 65 | 72 | 1.61 | $13,238 | $3,790 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,796 | $64 |
Medicaid work
$587,841 in 2024
Medicaid paid $587,841 for 13,698 billed services this clinician did in 2024, up to 234 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,346 | $574,571 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 133 | $7,964 |
| Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use | 25 | $2,951 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 95 | $1,742 |
| Return visit (30+ min) | 1,749 | $425 |
| Short return visit (20+ min) | 859 | $123 |
| Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use | 15 | $42 |
| Hemoglobin A1C level | 152 | $9 |
| Administration of patient-focused health risk assessment instrument (eg, health hazard appraisal) with scoring and documentation, per standardized instrument | 213 | $6 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 17 | $4 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 366 | $4 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 1,873 | $0 |
| 2024 | 13,698 | 23 | 234 | $587,841 |
| 2023 | 20,362 | 31 | 318 | $1,034,429 |
| 2022 | 2,505 | 5 | 190 | $197,620 |
| 2021 | 1,587 | 10 | 176 | $148,951 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 2,487 | $1,016,792 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 66 | $7,639 |
| Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use | 52 | $5,854 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 89 | $1,540 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 15 | $898 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 27 | $486 |
| Return visit (30+ min) | 1,947 | $386 |
| Short return visit (20+ min) | 2,037 | $372 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, booster dose | 28 | $140 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 80 | $111 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 165 | $97 |
| Developmental screening | 24 | $59 |
2022
| Clinic visit/encounter, all-inclusive | 966 | $194,304 |
| Short return visit (20+ min) | 907 | $1,715 |
| Return visit (30+ min) | 273 | $878 |
| Short return visit | 346 | $724 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 13 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 697 | $147,996 |
| Short return visit (20+ min) | 438 | $509 |
| Return visit (30+ min) | 124 | $307 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 71 | $50 |
| Short return visit | 116 | $49 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 15 | $41 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 14 | $0 |
| Pure tone audiometry (threshold); air only | 53 | $0 |
| Bilateral quantitative screening test of visual acuity | 44 | $0 |
| New patient visit (30+ min) | 15 | $0 |
Drugs they prescribed that Part D paid
$193,111
Pharmacies billed $193,111 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (26 of 1,457) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
1,116 generic and 287 brand-name prescriptions · $193,111 in drug cost · 83 antibiotic prescriptions to 54 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 29 | $31,940 | $1,101 |
| Jardiance | 27 | $20,711 | $767 |
| Rybelsus | 17 | $19,307 | $1,136 |
| Trulicity | 20 | $18,685 | $934 |
| Eliquis | 12 | $8,608 | $717 |
See all 42 drugs
| Ozempic | 29 | $31,940 | $1,101 |
| Jardiance | 27 | $20,711 | $767 |
| Rybelsus | 17 | $19,307 | $1,136 |
| Trulicity | 20 | $18,685 | $934 |
| Eliquis | 12 | $8,608 | $717 |
| Farxiga | 11 | $8,073 | $734 |
| Basaglar Kwikpen U-100 | 11 | $3,115 | $283 |
| Lantus Solostar | 14 | $1,273 | $91 |
| Atorvastatin | 126 | $1,163 | $9 |
| Albuterol Sulfate Hfa | 26 | $934 | $36 |
| Diclofenac | 17 | $504 | $30 |
| Gabapentin | 36 | $383 | $11 |
| Duloxetine | 13 | $265 | $20 |
| Losartan | 44 | $251 | $6 |
| Lisinopril | 52 | $232 | $4 |
| Metformin | 38 | $216 | $6 |
| Famotidine | 15 | $200 | $13 |
| Pantoprazole | 22 | $191 | $9 |
| Tamsulosin | 28 | $171 | $6 |
| Sertraline | 29 | $163 | $6 |
| Amlodipine Besylate | 46 | $160 | $3 |
| Montelukast | 18 | $154 | $9 |
| Spironolactone | 13 | $143 | $11 |
| Benazepril | 15 | $138 | $9 |
| Omeprazole | 21 | $128 | $6 |
| Fluticasone Propionate | 18 | $123 | $7 |
| Levothyroxine | 15 | $122 | $8 |
| Amoxicillin-Clavulanate Potass | 15 | $106 | $7 |
| Hydrocodone-Acetaminophen | 12 | $104 | $9 |
| Metformin Hcl Er | 14 | $98 | $7 |
| Naproxen | 14 | $96 | $7 |
| Carvedilol | 22 | $90 | $4 |
| Metoprolol | 11 | $80 | $7 |
| Ibuprofen | 13 | $74 | $6 |
| Furosemide | 14 | $67 | $5 |
| Alcohol Pads | 11 | $66 | $6 |
| Pregabalin | 16 | $63 | $4 |
| Topiramate | 11 | $62 | $6 |
| Baclofen | 13 | $55 | $4 |
| Hydrochlorothiazide | 24 | $38 | $2 |
| Paroxetine | 13 | $25 | $2 |
| Prednisone | 16 | $23 | $1 |
Year by year
| 2024 | 1,457 | 303 | 2% (26) | 20% | $193,111 |
| 2023 | 1,317 | 263 | 1% (14) | 22% | $218,665 |
| 2022 | 2,234 | 205 | 2% (38) | 17% | $241,772 |
| 2021 | 537 | 152 | None | None | $63,585 |
| 2020 | 346 | 51 | 0% (0) | None | $18,010 |
| 2019 | 38 | 15 | 0% (0) | None | $4,969 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 27 drugs
| Jardiance | 26 | $36,968 | $1,422 |
| Trulicity | 32 | $35,138 | $1,098 |
| Rybelsus | 18 | $23,083 | $1,282 |
| Ozempic | 13 | $12,440 | $957 |
| Symbicort | 32 | $12,132 | $379 |
| Eliquis | 11 | $11,437 | $1,040 |
| Basaglar Kwikpen U-100 | 12 | $2,995 | $250 |
| Diclofenac | 26 | $2,035 | $78 |
| Atorvastatin | 98 | $1,959 | $20 |
| Albuterol Sulfate Hfa | 21 | $854 | $41 |
| Omeprazole | 32 | $812 | $25 |
| Losartan | 59 | $531 | $9 |
| Levothyroxine | 46 | $530 | $12 |
| Metformin | 36 | $499 | $14 |
| Amlodipine Besylate | 53 | $468 | $9 |
| Lisinopril | 41 | $389 | $9 |
| Metformin Hcl Er | 19 | $380 | $20 |
| Gabapentin | 25 | $365 | $15 |
| Tamsulosin | 16 | $315 | $20 |
| Finasteride | 14 | $232 | $17 |
| Pravastatin | 21 | $210 | $10 |
| Fluticasone Propionate | 19 | $182 | $10 |
| Hydrochlorothiazide | 41 | $141 | $3 |
| Ibuprofen | 15 | $119 | $8 |
| Topiramate | 11 | $75 | $7 |
| Carvedilol | 16 | $60 | $4 |
| Clopidogrel | 12 | $38 | $3 |
2022: 44 drugs
| Jardiance | 55 | $55,172 | $1,003 |
| Trulicity | 43 | $47,946 | $1,115 |
| Rybelsus | 17 | $20,952 | $1,232 |
| Synjardy | 17 | $14,798 | $870 |
| Symbicort | 20 | $7,096 | $355 |
| Basaglar Kwikpen U-100 | 16 | $3,551 | $222 |
| Flovent Hfa | 11 | $2,855 | $260 |
| Atorvastatin | 145 | $2,129 | $15 |
| Pravastatin | 123 | $1,727 | $14 |
| Albuterol Sulfate Hfa | 39 | $1,513 | $39 |
| Levothyroxine | 119 | $1,311 | $11 |
| Tamsulosin | 33 | $1,186 | $36 |
| Amlodipine Besylate | 156 | $1,142 | $7 |
| Metformin | 107 | $1,102 | $10 |
| Omeprazole | 83 | $938 | $11 |
| Metoprolol | 38 | $876 | $23 |
| Losartan | 102 | $791 | $8 |
| Baclofen | 12 | $612 | $51 |
| Enalapril Maleate | 12 | $611 | $51 |
| Lisinopril | 56 | $459 | $8 |
| Clotrimazole | 14 | $456 | $33 |
| Montelukast | 17 | $454 | $27 |
| Diclofenac | 25 | $425 | $17 |
| Gabapentin | 37 | $368 | $10 |
| Fluticasone Propionate | 28 | $356 | $13 |
| Metoprolol | 36 | $353 | $10 |
| Hydrocodone-Acetaminophen | 20 | $348 | $17 |
| Clopidogrel | 61 | $306 | $5 |
| Hydrochlorothiazide | 66 | $259 | $4 |
| Propranolol | 15 | $228 | $15 |
| Carvedilol | 44 | $218 | $5 |
| Alendronate | 32 | $190 | $6 |
| Simvastatin | 14 | $178 | $13 |
| Famotidine | 31 | $161 | $5 |
| Benazepril | 12 | $141 | $12 |
| Pregabalin | 14 | $140 | $10 |
| Venlafaxine Hcl Er | 12 | $129 | $11 |
| Trazodone | 13 | $123 | $9 |
| Escitalopram | 14 | $113 | $8 |
| Naproxen | 19 | $103 | $5 |
| Hydroxyzine | 13 | $79 | $6 |
| Cyclobenzaprine | 12 | $66 | $5 |
| Glipizide | 15 | $65 | $4 |
| Furosemide | 11 | $33 | $3 |
2021: 15 drugs
| Jardiance | 18 | $14,671 | $815 |
| Trulicity | 11 | $9,576 | $871 |
| Atorvastatin | 31 | $628 | $20 |
| Duloxetine | 16 | $624 | $39 |
| Tamsulosin | 14 | $367 | $26 |
| Diclofenac | 13 | $348 | $27 |
| Levothyroxine | 16 | $340 | $21 |
| Pravastatin | 30 | $277 | $9 |
| Metformin | 32 | $179 | $6 |
| Amlodipine Besylate | 28 | $167 | $6 |
| Fluticasone Propionate | 14 | $142 | $10 |
| Gabapentin | 12 | $135 | $11 |
| Lisinopril | 19 | $108 | $6 |
| Losartan | 12 | $102 | $9 |
| Omeprazole | 12 | $89 | $7 |
2020: 9 drugs
| Buprenorphine-Naloxone | 11 | $720 | $65 |
| Atorvastatin | 24 | $346 | $14 |
| Gabapentin | 15 | $191 | $13 |
| Losartan | 20 | $183 | $9 |
| Metformin | 19 | $143 | $8 |
| Lisinopril | 23 | $114 | $5 |
| Amlodipine Besylate | 20 | $106 | $5 |
| Sertraline | 11 | $86 | $8 |
| Pantoprazole | 12 | $62 | $5 |
Money from drug and device companies
$17 in 2025
| 2025 | 1 | 1 | None | $17 |
| 2023 | 1 | 1 | None | $24 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Dexcom | Dexcom G6 Transmitter | $17 | 1 payment
|
See the published payment
| Dexcom | Meals · 2025-10-01 | Dexcom G6 Transmitter | $17 |
See earlier years (2023)
2023: $24
| Abbott Laboratories | Freestyle Libre 3 | $24 | 1 payment
|
Professional record
- NPI
- 1043717218
- Licence
- CA A163467California A163467: Current · expires 2027-07-31
- Trained
- University of California, Irvine, California College of Medicine, 2018
- Group
- Stanford Health Care · Faculty Physicians and Surgeons of Llusm · Sac Health System · County of Santa Clara
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Family medicine (207Q00000X); Student in a training program (390200000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2018-04-12
- NPI last updated
- 2026-04-17
- NPI record certified
- 2026-04-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 25333 Barton Rd, Loma Linda, CA, 92350 · 250 S G St, San Bernardino, CA, 92410